Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling

Advancing Prognostic Assessment in Pediatric Acute Myeloid Leukemia with KMT2A Rearrangement: Integrating Transcriptomic Profiling

2024.02.28
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Hemasphere. The title of the study is "Integration of Transcriptomic Features to Improve Prognosis Prediction of Pediatric Acute Myeloid Leukemia With KMT2A Rearrangement". The study represents a significant advancement in the prognostic assessment of pediatric acute myeloid leukemia (AML) with KMT2A rearrangement.
Establishment of a Prognostic Model and Tumor Clustering for Pediatric Acute Myeloid Leukemia Patients: Leveraging the Fanconi Anemia Signaling Pathway to Enhance Clinical Management

Establishment of a Prognostic Model and Tumor Clustering for Pediatric Acute Myeloid Leukemia Patients: Leveraging the Fanconi Anemia Signaling Pathway to Enhance Clinical Management

2024.02.28
In November 2023, a  study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Open Medicine(Wars). The title of the study is "Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients". This study heralds the establishment of a novel prognostic model and tumor clustering approach tailored specifically for pediatric AML, anchored in the FA signaling pathway.